Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

7.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Toxoplasma gondii Infection and Drug Addiction: Evidence from a Case-Control Study.

Infectious disorders drug targets·2026
Same author

Retraction of "3D Protein-Based Bilayer Artificial Skin for the Guided Scarless Healing of Third-Degree Burn Wounds in Vivo".

Biomacromolecules·2026
Same author

Insights into cellulose nanocrystals-based bioinks for 3D bioprinting in regenerative medicine and tissue engineering: A review.

International journal of biological macromolecules·2025
Same author

Effects of aerial parts of Oliveria decumbens and Trachyspermum ammi aromatherapy on hematological parameters and tissue histopathology in female rats.

Journal of molecular histology·2025
Same author

Substrate engineering using naturally biomimicking corneal cell topography for preserving stemness of corneal limbal epithelial-stem cells.

Iranian journal of basic medical sciences·2025
Same author

Cytotoxic effects of epsilon toxin from <i>Clostridium perfringens</i> on colon cancer cell lines (HT-29) and (Caco2) in terms of oxidative stress and inflammatory cytokines.

Toxicology research·2025

Related Experiment Video

Updated: Mar 18, 2026

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique
07:13

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Published on: May 2, 2025

937

Advancements in Promoting Angiogenesis in Tissue-Engineered Grafts in Various Organs: A Comprehensive Review.

Saeedeh Zare Jalise1, Peiman Brouki Milan2, Elham Kialashaki3

  • 1Department of Tissue Engineering and Applied Cell Sciences, School of Medicine, Qom University of Medical Sciences, Qom, Iran.

Macromolecular Bioscience
|March 17, 2026
PubMed
Summary

This review details strategies to improve blood vessel formation (angiogenesis) in tissue engineering. Advances in biomaterials, cell therapies, and technologies like 3D bioprinting are key to overcoming graft limitations.

Keywords:
angiogenesisbiomaterialsgrowth factorsorgansregenerative medicine

More Related Videos

The Arteriovenous AV Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering
08:53

The Arteriovenous AV Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering

Published on: November 2, 2016

13.1K
Implantation of Inferior Vena Cava Interposition Graft in Mouse Model
12:39

Implantation of Inferior Vena Cava Interposition Graft in Mouse Model

Published on: June 4, 2014

12.6K

Related Experiment Videos

Last Updated: Mar 18, 2026

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique
07:13

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Published on: May 2, 2025

937
The Arteriovenous AV Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering
08:53

The Arteriovenous AV Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering

Published on: November 2, 2016

13.1K
Implantation of Inferior Vena Cava Interposition Graft in Mouse Model
12:39

Implantation of Inferior Vena Cava Interposition Graft in Mouse Model

Published on: June 4, 2014

12.6K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Vascular Biology

Background:

  • Vascularization is critical for engineered tissue survival and function.
  • Ischemia post-implantation limits graft success.
  • Natural vascular development provides a blueprint for engineered solutions.

Purpose of the Study:

  • To review recent advancements in promoting angiogenesis in tissue-engineered constructs.
  • To explore strategies mimicking natural vascular development.
  • To identify challenges and future directions in vascular integration for regenerative medicine.

Main Methods:

  • Controlled delivery of pro-angiogenic growth factors (VEGF, FGF, PDGF).
  • Development of bioactive and mechanically tuned biomaterials (collagen, gelatin, hyaluronic acid, decellularized matrices).
  • Cell-based approaches using stem and progenitor cells (ESCs, iPSCs, MSCs).
  • Application of novel technologies like 3D bioprinting and nanofabrication.
  • Exploration of unconventional inducers like parasite-derived proteins.

Main Results:

  • Multiple strategies show promise for enhancing vascularization in engineered tissues.
  • 3D bioprinting and extracellular vesicles offer improved control over vascular network formation.
  • Organ-specific applications demonstrate translational potential across diverse tissues.
  • Unconventional angiogenic inducers present novel therapeutic avenues.

Conclusions:

  • Achieving stable, long-term vascularization remains a significant challenge.
  • Synchronizing vascularization with lymphangiogenesis and immunomodulation is crucial.
  • Regulatory hurdles must be addressed for clinical translation.
  • Interdisciplinary collaboration is essential for developing functional tissue replacements.